BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9729143)

  • 1. Lovastatin for X-linked adrenoleukodystrophy.
    Singh I; Khan M; Key L; Pai S
    N Engl J Med; 1998 Sep; 339(10):702-3. PubMed ID: 9729143
    [No Abstract]   [Full Text] [Related]  

  • 2. Lovastatin in X-linked adrenoleukodystrophy.
    Engelen M; Ofman R; Dijkgraaf MG; Hijzen M; van der Wardt LA; van Geel BM; de Visser M; Wanders RJ; Poll-The BT; Kemp S
    N Engl J Med; 2010 Jan; 362(3):276-7. PubMed ID: 20089986
    [No Abstract]   [Full Text] [Related]  

  • 3. Lovastatin therapy for X-linked adrenoleukodystrophy: clinical and biochemical observations on 12 patients.
    Pai GS; Khan M; Barbosa E; Key LL; Craver JR; Curé JK; Betros R; Singh I
    Mol Genet Metab; 2000 Apr; 69(4):312-22. PubMed ID: 10870849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
    McGuinness MC; Zhang HP; Smith KD
    Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [X-linked adrenoleukodystrophy (ALD)].
    Imamura A; Suzuki Y
    Nihon Rinsho; 2004 Jan; 62 Suppl():389-92. PubMed ID: 15011392
    [No Abstract]   [Full Text] [Related]  

  • 6. Lovastatin does not correct the accumulation of very long-chain fatty acids in tissues of adrenoleukodystrophy protein-deficient mice.
    Yamada T; Shinnoh N; Taniwaki T; Ohyagi Y; Asahara H; Horiuchi ; Kira J
    J Inherit Metab Dis; 2000 Sep; 23(6):607-14. PubMed ID: 11032335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil.
    Poulos A; Gibson R; Sharp P; Beckman K; Grattan-Smith P
    Ann Neurol; 1994 Nov; 36(5):741-6. PubMed ID: 7979219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Examination of very long chain fatty acids in diagnosis of x-linked adrenoleukodystrophy].
    Stradomska TJ; Tylki-Szymańska A
    Pediatr Pol; 1996 Mar; 71(3):197-201. PubMed ID: 8966090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diet therapy with erucic acid in patients with X-linked adrenoleukodystrophy].
    Uziel G; Bertini E; Bardelli P; Rimoldi M; Gambetti M
    Minerva Pediatr; 1991 Mar; 43(3):127-31. PubMed ID: 1870507
    [No Abstract]   [Full Text] [Related]  

  • 10. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS; Bacon SP; Illingworth DR
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors.
    Tobert JA
    Nat Rev Drug Discov; 2003 Jul; 2(7):517-26. PubMed ID: 12815379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility to oxidation of plasma low-density lipoprotein in X-linked adrenoleukodystrophy: effects of simvastatin treatment.
    Di Biase A; Salvati S; Varí R; Avellino C; Sforza F; Cappa M; Masella R
    Mol Genet Metab; 2000 Dec; 71(4):651-5. PubMed ID: 11136559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A "natural" remedy for high cholesterol.
    Johns Hopkins Med Lett Health After 50; 1999 Jul; 11(5):3. PubMed ID: 10377908
    [No Abstract]   [Full Text] [Related]  

  • 14. Simvastatin and plasma very-long-chain fatty acids in X-linked adrenoleukodystrophy.
    Verrips A; Willemsen MA; Rubio-Gozalbo E; De Jong J; Smeitink JA
    Ann Neurol; 2000 Apr; 47(4):552-3. PubMed ID: 10762175
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of lovastatin and pentoxyphyllin in nonalcoholic steatohepatitis.
    Mihaila RG; Nedelcu L; Fratila O; Rezi EC; Domnariu C; Deac M
    Hepatogastroenterology; 2009; 56(93):1117-21. PubMed ID: 19760953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nicotinic acid and lovastatin in combination with cholestyramine in renal transplant patients.
    Lal SM; Katyal A
    Mo Med; 2002; 99(10):580-4. PubMed ID: 12534147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenomyeloneuropathy.
    Dickey W; Lyttle JA; Sawhney BB; Kennedy L
    Ulster Med J; 1987 Oct; 56(2):149-51. PubMed ID: 3445395
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteins.
    Richter WO; Jacob BG; Schwandt P
    Int J Tissue React; 1991; 13(2):107-10. PubMed ID: 1955291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins & Alzheimer's.
    Feinberg AW
    Health News; 2000 Dec; 6(12):1. PubMed ID: 11142934
    [No Abstract]   [Full Text] [Related]  

  • 20. [Backache as the initial symptom of adrenomyeloneuropathy].
    Benito-León J; Zamorano T; Martín-Peña G; Tapia MA; Alvarez-Linera J
    Rev Neurol; 2000 Dec 16-31; 31(12):1167-70. PubMed ID: 11205553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.